12.35
price up icon0.57%   0.07
after-market Dopo l'orario di chiusura: 13.05 0.70 +5.67%
loading
Precedente Chiudi:
$12.28
Aprire:
$12.28
Volume 24 ore:
377.34K
Relative Volume:
0.87
Capitalizzazione di mercato:
$349.86M
Reddito:
$157.75M
Utile/perdita netta:
$-29.73M
Rapporto P/E:
-10.65
EPS:
-1.16
Flusso di cassa netto:
$-21.00M
1 W Prestazione:
-0.72%
1M Prestazione:
+6.01%
6M Prestazione:
-16.67%
1 anno Prestazione:
-52.43%
Intervallo 1D:
Value
$12.10
$12.98
Intervallo di 1 settimana:
Value
$12.01
$13.42
Portata 52W:
Value
$8.04
$28.05

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name
Nome
Arcturus Therapeutics Holdings Inc
Name
Telefono
(858) 900-2660
Name
Indirizzo
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
Dipendente
176
Name
Cinguettio
@ArcturusRx
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
ARCT's Discussions on Twitter

Confronta ARCT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ARCT
Arcturus Therapeutics Holdings Inc
12.35 349.86M 157.75M -29.73M -21.00M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
448.40 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
513.58 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
312.32 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
537.92 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
252.78 28.51B 3.81B -644.79M -669.77M -6.24

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-28 Iniziato Scotiabank Sector Outperform
2025-01-28 Iniziato BTIG Research Buy
2024-08-12 Iniziato Leerink Partners Outperform
2023-12-13 Iniziato Canaccord Genuity Buy
2023-07-24 Iniziato William Blair Outperform
2023-05-11 Aggiornamento H.C. Wainwright Neutral → Buy
2022-11-14 Ripresa Wells Fargo Overweight
2022-11-10 Downgrade Robert W. Baird Neutral → Underperform
2022-11-03 Aggiornamento Citigroup Neutral → Buy
2022-11-02 Aggiornamento Barclays Underweight → Equal Weight
2022-08-10 Downgrade Raymond James Mkt Perform → Underperform
2022-07-19 Ripresa Cantor Fitzgerald Overweight
2022-05-11 Aggiornamento Robert W. Baird Underperform → Neutral
2022-04-21 Downgrade Citigroup Buy → Neutral
2022-01-31 Aggiornamento Raymond James Underperform → Mkt Perform
2021-08-12 Downgrade Raymond James Mkt Perform → Underperform
2021-08-11 Downgrade Goldman Neutral → Sell
2021-08-10 Downgrade Robert W. Baird Neutral → Underperform
2021-07-02 Iniziato Cantor Fitzgerald Overweight
2021-06-25 Ripresa Goldman Neutral
2021-06-21 Downgrade Barclays Equal Weight → Underweight
2021-06-04 Ripresa Robert W. Baird Neutral
2021-02-17 Downgrade B. Riley Securities Neutral → Sell
2021-01-19 Downgrade B. Riley Securities Buy → Neutral
2021-01-15 Downgrade B. Riley Securities Buy → Neutral
2021-01-07 Iniziato Wells Fargo Overweight
2020-12-29 Downgrade Barclays Overweight → Equal Weight
2020-12-29 Downgrade H.C. Wainwright Buy → Neutral
2020-12-29 Downgrade Raymond James Outperform → Mkt Perform
2020-12-29 Downgrade Robert W. Baird Outperform → Neutral
2020-12-23 Downgrade ROTH Capital Buy → Sell
2020-12-08 Reiterato B. Riley Securities Buy
2020-12-07 Reiterato B. Riley Securities Buy
2020-10-26 Iniziato Barclays Overweight
2020-10-06 Iniziato Citigroup Buy
2020-08-26 Iniziato Piper Sandler Overweight
2020-07-30 Ripresa ROTH Capital Buy
2020-07-16 Iniziato Raymond James Outperform
2020-07-13 Iniziato B. Riley FBR Buy
2020-06-09 Downgrade WBB Securities Buy → Hold
2020-02-11 Iniziato Robert W. Baird Outperform
2020-02-07 Iniziato Guggenheim Buy
2020-02-06 Iniziato Guggenheim Buy
2019-04-05 Iniziato H.C. Wainwright Buy
2018-09-20 Aggiornamento WBB Securities Buy → Strong Buy
2018-01-22 Iniziato Chardan Capital Markets Buy
Mostra tutto

Arcturus Therapeutics Holdings Inc Borsa (ARCT) Ultime notizie

pulisher
Jun 12, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Sold by Bank of America Corp DE - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Analysts Offer Predictions for ARCT FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Two Sigma Investments LP Increases Stock Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Jun 10, 2025
pulisher
Jun 10, 2025

(ARCT) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Sells 22,752 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Is A Good Stock To Invest In - Stocksregister

Jun 07, 2025
pulisher
Jun 06, 2025

Arcturus Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Transcript : Arcturus Therapeutics Holdings Inc.Shareholder/Analyst Call - marketscreener.com

Jun 06, 2025
pulisher
Jun 06, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Position Increased by Ameriprise Financial Inc. - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Sells 10,221 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Sells 13,093 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Wall Street Analysts Think Arcturus Therapeutics (ARCT) Could Surge 371.35%: Read This Before Placing a Bet - sharewise

Jun 03, 2025
pulisher
May 31, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Purchased by Deutsche Bank AG - Defense World

May 31, 2025
pulisher
May 29, 2025

Arcturus Therapeutics to Attend Upcoming Investor Conferences - Business Wire

May 29, 2025
pulisher
May 29, 2025

Arcturus Therapeutics (NASDAQ:ARCT) Now Covered by Analysts at Scotiabank - Defense World

May 29, 2025
pulisher
May 28, 2025

Scotiabank Initiates Coverage of Arcturus Therapeutics Holdings (ARCT) with Sector Outperform Recommendation - Nasdaq

May 28, 2025
pulisher
May 28, 2025

When the Price of (ARCT) Talks, People Listen - news.stocktradersdaily.com

May 28, 2025
pulisher
May 28, 2025

Scotiabank Initiates Coverage on Arcturus Therapeutics (ARCT) | - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Arcturus Therapeutics (ARCT) Receives Positive Outlook with Potential Upside | ARCT Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Scotiabank Initiates Arcturus Therapeutics at Outperform - marketscreener.com

May 28, 2025
pulisher
May 27, 2025

Man Group plc Sells 4,168 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 27, 2025
pulisher
May 24, 2025

Arcturus Therapeutics’ SWOT analysis: mRNA innovator’s stock faces pivotal year - Investing.com India

May 24, 2025
pulisher
May 24, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Recommendation of “Buy” by Brokerages - Defense World

May 24, 2025
pulisher
May 24, 2025

Wall Street Zen Upgrades Arcturus Therapeutics (NASDAQ:ARCT) to “Hold” - Defense World

May 24, 2025
pulisher
May 22, 2025

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A 481% Upside Potential Amidst Biotech Innovations - DirectorsTalk Interviews

May 22, 2025
pulisher
May 22, 2025

Northern Trust Corp Has $4.35 Million Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 22, 2025
pulisher
May 18, 2025

Trend Tracker for (ARCT) - news.stocktradersdaily.com

May 18, 2025
pulisher
May 17, 2025

Wells Fargo & Company Cuts Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $45.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

Arcturus signals extended cash runway into 2028 with strategic shift toward CF and OTC mRNA therapeutics - MSN

May 16, 2025
pulisher
May 16, 2025

FY2025 EPS Estimates for ARCT Raised by Cantor Fitzgerald - The AM Reporter

May 16, 2025
pulisher
May 16, 2025

Leerink Partnrs Analysts Raise Earnings Estimates for ARCT - Defense World

May 16, 2025
pulisher
May 16, 2025

Price T Rowe Associates Inc. MD Increases Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World

May 16, 2025
pulisher
May 16, 2025

William Blair Brokers Boost Earnings Estimates for ARCT - Defense World

May 16, 2025
pulisher
May 15, 2025

Wall Street Analysts Believe Arcturus Therapeutics (ARCT) Could Rally 503.6%: Here's is How to Trade - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Canaccord Genuity Group Issues Pessimistic Forecast for Arcturus Therapeutics (NASDAQ:ARCT) Stock Price - Defense World

May 15, 2025
pulisher
May 14, 2025

Arcturus Therapeutics (ARCT): Wells Fargo Maintains Rating, Lowe - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025
pulisher
May 14, 2025

Wells Fargo Adjusts Price Target for Arcturus Therapeutics (ARCT) | ARCT Stock News - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Arcturus Therapeutics (ARCT) Set for Potential Upside with Citi's Confidence | ARCT Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc earnings missed by $4.11, revenue fell short of estimates - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Canaccord Genuity Maintains Buy Rating on Arcturus Therapeutics (ARCT) | ARCT Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Demystifying Arcturus Therapeutics: Insights From 7 Analyst Reviews - Benzinga

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics (ARCT) Price Target Revised by Canaccord | - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings: EPS - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call Highlights: Strategic Focus and ... - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics stock jumps 7% despite Q1 loss By Investing.com - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2025 Earnings Call - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Arcturus Therapeutics Reports Q1 2025 Financial Update - TipRanks

May 13, 2025
pulisher
May 12, 2025

Arcturus Therapeutics (ARCT) Sees Strong Progress with Pipeline Programs - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Earnings call transcript: Arcturus Therapeutics Q1 2025 sees revenue drop, stock rises - Investing.com

May 12, 2025

Arcturus Therapeutics Holdings Inc Azioni (ARCT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$21.56
price down icon 2.13%
$34.91
price up icon 1.01%
$20.16
price up icon 1.56%
$99.46
price down icon 0.82%
$104.40
price down icon 0.54%
biotechnology ONC
$252.78
price down icon 0.52%
Capitalizzazione:     |  Volume (24 ore):